Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report

RATIONALE: Fondaparinux, as a factor Xa-inhibitor, is used off label to manage heparin-induced thrombocytopenia (HIT), but little experience with HIT patients has been reported in the literature. Moreover, the use of fondaparinux for full anticoagulation in critically ill patients with HIT and renal...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yumiao, He, Huaiwu, Liu, Dawei, Long, Yun, Su, Longxiang, Cheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156017/
https://www.ncbi.nlm.nih.gov/pubmed/30212955
http://dx.doi.org/10.1097/MD.0000000000012236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156017/
https://www.ncbi.nlm.nih.gov/pubmed/30212955
http://dx.doi.org/10.1097/MD.0000000000012236

Ejemplares similares